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molecules, which then act in competition for the activation sites of 
the operbns or regulons under quorum sensing control. Control of 
pathogenicity in this way may offer a unique form of antimicrobial 
therapy without the endotoxemia associated with Gram-negative cell 
lysis. 
FI A new approach for controlling bacterial popu- 
lations (sonic communication with bacterial 
M. Matsushashi, A.N. Pankrushina, K. Endoh, S. Endo, 
H. Ohshima, S. Takeuchi, A. Shindo, M. Tobi, H. Yamamura, 
T. Tomari, E. Masaka, S. Hiraoka, N. Hiraoka, S. Takayanagi, 
A. Fujino. Tokai University, Biological Science, Numazu, japan 
Introduction and  objectives: We previously reported that bacteria 
communicate with each other by using growth-regulating sonic/ 
ultrasonic signals (Matsuhashi et al, J Gen Appl Microbiol 1996; 42: 
315-323). Barillus subtilis cells emit sounds at frequencies ofabout 8.5 
kHz and its overtones, and the growth of B. carboniphilus cells is 
promoted by sounds/ultrasounds from a speaker at similar frequencies 
under non-permissive stress conditions (Matsuhashi et al, J Gen Appl 
Microbiol 1998; 44: 49-55). Graphite, charcoal and other materials 
convert external energy, such as pulses of infrared light, into sonic 
signals (Matsuhashi et al, J Gen Appl Microbiol 1997; 43: 225-230). 
The response of bacteria to sounds may be utilized in antibiotic 
therapy. 
Results: (1) Soft solid matter, such as solidified agar in growth 
media, can significantly promote or inhibit the growth of bacteria 
and yeast under stress conditions and the hatching of fish eggs. The 
effect is probably due to photo-acoustic emission resulting from the 
conversion of external electromagnetic energy and can be diminished 
by shielding the agar and organisms with aluminum foil. E. coli and 
yeasts also responded to signals from the agar. This mechanism 
probably explains why many bacteria and mycoplasmas grow well on 
soft solid surfaces such as animal tissue. (2) In contrast to B. 
carboniphilus, soft low-frequency sounds from a speaker, at frequencies 
between 10 and 800 Hz, markedly inhibit the growth of E. coli. This 
E. coli behavior, which may be common in related Gram-negative 
bacilli, suggests that low-frequency sounds may help to overcome 
infections by Gram-negative bacteria. 
w] Quorum sensing-a new target for antibiotic 
therapy 
P. Williams. University $ Nottingham, Pltarinacrutical Sciences/lnstitute 
o f  Infections G University Park, Nottingham, UK 
There are two broad strategies for controlling bacterial infection: 
either (1) kill the organism or (2) attenuate virulence such that the 
infecting oragnism fails to adapt to the host environment and can be 
cleared by the innate host defenses. The latter approach has, until 
recently, lacked specific targets for rational drug design. However, the 
discovery that bacterial cells communicate with each other using 
small diffusible signaling molecules to regulate virulence in concert 
with cell population density (termed quorum sensing) now offers 
such a novel target. 
Many Gram-negative bacteria employ N-acylhomoserine lactones 
(AHLs) as quorum sensing signaling molecules which not only 
control gene expression but also possess potent pharmacologic 
activities such that they may function as virulence determinants per 
se. Understanding the molecular mechanisms by which AHLs are 
produced (usually via a member of the Lux family of AHL synthases) 
and by which AHLs activate target gene expression (via members of 
thr LuxR family of transcriptional regulators) is central to the design 
of small-molecule antagonists (Quorum Sensing Blockers, QSBs) 
capable of attenuating virulence through the blockade of either signal 
generation or signal transduction. 
Toxicity of antimicrobial agents: relevance of 
preclinicai data for the clinician 
Is671 Immunologic reactions to antimicrobial agents 
A. Cerny. I t d p i r d  / Deparrmrnt of Innere Medizin, Berne, 
Switzerland 
This presentation reviews the incidence, clinical manifestations, 
differential diagnosis, risk factors and pathogenesis of allergic 
reactions of two important classes of antimicrobials; beta-lactams and 
sulfonamides. The diagnostic work-up of a patient with a history of 
an allergic reaction will be discussed, as well as the possibility of the 
safe administration of the drug in the face of an allergy using 
immunotherapy Emerging concepts of beta-lactam side-chain 
allergy, the role of cellular immune mechanisms and the clinical 
importance of cross-reactivity of allergic reactions to different classes 
of beta-lactams will be emphasized. 
Is681 Toxic effects of antimicrobial agents on the 
musculoskeletal system 
R. Stahlmann. Freie Universitiit Berlin, Institutfur Toxikologie, Berlin, 
Germany 
Several groups of antimicrobial agents have the potential to have 
adverse effects on the musculoskeletal system. At the beginning of 
the 1960s, the effects of tetracycline on the developing skeleton were 
investigated in premature infants by multiple X-ray examinations. 
Based on these results, tetracylines were considered to be contra- 
indicated in infants and children. Quinolones are another group of 
frequently used drugs that have toxic effects on connective tissue 
structures. Due to their cartilage toxicity-as shown in immature 
dogs and other animals-they are contraindicated in children and 
adolescents. Human experience with pefloxacin in children showed 
an unacceptably high incidence of joint toxicity (10%). However, 
with nalidixic acid, norfloxacin and ciprofloxacin, favorable clinical 
results in juvenile patients have been published. Also, quinolones have 
the potential to induce tendon disorders (tendinitis, Achilles tendon 
rupture) which have occurred mainly in elderly patients. Mechanistic 
studies from our group indicate that the magnesium-chelating 
properties of the quinolones might be responsible for these toxic 
effects. Less often used antimicrobial drugs which might affect the 
musculoskeletal system include, for example, pyrazinamide, rifabutin, 
and quinupristin-dalfopristin. 
Infectious disease problems in Central and 
Eastern Europe 
Typical problems of infectious diseases in 
Central Europe 
E. Ludwig. Petefy Eachiny Hospital, Budapest, Hungary 
Central and eastern European countries face the same types of 
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problems concerning infectious diseases as the majority of the other 
European countries, but these problems can be much more pro- 
nounced in particular countries, depending on the local conditions. 
The abuse of antimicrobials is especially heavy in the outpatient 
setting. This problem is aggravated by the rapid increase in the 
number of registered antibiotics since the early 1990s, which almost 
inevitably results in the incorrect use of then]. 
The bacterial resistance rates vary from country to country; in 
Hungary they are close to those published in Spain. The correct 
figures are unknown due to the lack of large-scale, standardized 
surveillance programs, and the small studies reflect only the local 
situation. The most important problem bacteria are the penicillin- 
resistant pneumococci, in some institutions MRSA/MKSE, and the 
multidrug-resistant Gram-negative rods. The VRE do not pose ‘I 
problem in this region. 
Shortage of money induces attempts to decrease the share of 
antiniicrobials in the hospital budget. These attempts, however, 
consider only the purchase price of antim~crobials and urge the use 
of cheaper ones. The restrictions do not result in the rational use of 
antibiotics, but rather in the suboptimal treatment of patients. 
There is no modern infection control in the majority of hospitdls. 
The influence of infectologists/clinical microbiologists on the 
daily practice of medical doctors is fairly poor. 
ml Molecular epidemiology of MRSA in Poland 
W. Hryniewicz, K. Trzcinski. Sera arid Varcines, Research Lab., 
Warsalv, Polatid 
Methicillin-resistant Staphylococcus aureus (MRSA) was reported in  
Poland in the early 196Os, long before this drug was introduced in 
the country. However, the first studies on their spread and prevalence 
started in the 1990s, when no single hospital was free from MKSA. 
At the same time, a several genotypic methods were introduced into 
the epidemiologic investigations on MRSA. Over 600 MRSA strains 
collected in hospitals scattered over the whole country were typed 
and analyzed by soiiie of these methods. The first was pulsed-field 
gel electrophoresis of SniaI-digested DNA, followed by arbitrary 
primed PCK (AP-PCR), and randomly amplified polymorphic 
DNA (RAP])) analysis, restriction fragment length polymorphism 
(RFLP) analysis of plasmid DNA, and of selected genes (e.g. spa, coa), 
analysis of mecA polymorphs and Tn554 insertion. Studies from 
1990-92 revealed the spread of two different clusters of MRSA 
strains. Isolates of the first cluster were always heterogeneously 
resistant to methicillin and usually susceptible to almost all other 
antistaphylococcal drugs with the exception of tetracycline. MRSA 
strains of the second cluster expressed homogeneous resistance to 
methicillin and were always uiultidrug resistant. Since that time, 
spread of these two clusters within the country has been analyzed. 
This has resulted in identification of the first outbreak of niupirocin- 
resistant MRSA in 1994 and its intra-hospital spread during the 
following years. A new epidemic of MRSA in the northeast of 
Poland in 1996 and an epidemic of MRSA with a defect of clumping 
factor production were also identified. Phenotypic and genotypic 
studies on a large collection of MRSA strains froin Poland resulted 
in characterization of Polish MRSA strains and a better 
understanding of their epidemiology. 
ml Meningococcal invasive disease in central 
Europe 
P. Kriz, M. Musilek. NRL G WHO h i 1 f i n r i O J 1 ,  D c p  If Hart.  K ~ r p  
h f i c t i o t r ,  PraCpe, Czech Republic 
Objectives: To assess the influence of ET-15/37 clone on ii i \~ciwe 
ineiiingococcal disease in some European countries. 
Methods: The laboratory data presrnted a t  the meetings of the 
European Monitoring Group 011 Meningococci were andyzcd .  
These data have been collected since 1993 froin the Czech Republic. 
Slovakia, Poland, Austria and Germany. They were compared with 
thr data analyzed in 1987. The selected Il’eisrcria wwiripr;dix  str,iin\ 
idcntified in the countries mentioned above were referred to the 
National Reference Laboratory for Meningococcal Infcc t~ons  i n  
I’rag~e for multilocus enzyme electrophoresis (MLEEj .~nd pultcd- 
field gel electrophoresis (PFGE). 
Results: In the Czech Republic, meningococcnl invasive diwase 
occurred sporadically in the past. This situation changed drdniaticdly 
in 1993 when a new meningococcal clone was detected. This clone 
was identified by MLEE as clone ET-15, belonging to the 37 corn- 
plex, with the prevailing phenotype C2a:Pl  .2,1’1 .5 (80’%j. The 
incidence and fatality rate of the disease increased, particularly in  thc 
age group 15-19 years. In Slovakia, this clone wa5 found i n  199.i, 
causing a similar change in the epidemiologic1 and clinical sittiatioii. 
I11 Austria, Germany and Poland, Ncisscria menin<$idis strain\ beloiig- 
ing to the ET-15/37 complex were found recently; howevcr, thcy 
remain infrequent and the total incidence of invasive nieniiigoci)ccal 
disease has not increased. PFGE ofselected strain, revealcd differences 
between the strains isolated in different countric,. 
Conclusions: In some European countries, 
strains belonging to the ET-l5/37 clone caused invasive meningo- 
coccal disease requiring special therapeutic and preventive measure\. 
Antibiotic policy in Russia 
L.S. Stratchounski. State Medical Acadertty, Sntolcwsk, Rttssra 
During the last 2 years, substantial progress ha, been made i n  the 
issues related to antibiotic policy in Russia. This became possible 
because active implementation of formulary system in the hospital, 
has been initiated by Ministry of Health, and the efforts of piiblic 
organizations such as the Commission on Antibiotic I’ohcy of 
Ministry of Health, the Inter-regional Association 0 1 1  C l i n i c ~ l  
Microbiology and Antiiiiicrobial Chemotherapy (IACMACj, ctc. 
Also, a lot of attention is paid to the antibiotic policy questions ,it the 
biggest Russian annual congresses on humans and medicine. Vt.ry 
good educationd support for rational antibiotic policy hds coiiie froin 
the ESCMID, ISC, ASM, FESCI and APUA. Another potitivc 
driving force has come from the pharmxcutical i n d u q  ~ n d  iiiicro- 
biological companies at local, regional and federd levels. In aidition, 
multicenter, well-designed inicrobiological in vitro studies have been 
conducted, and their results were taken into consideration during the 
development of local antibiotic formularies. However, there are still 
some specific problems in the implementatioii of rational aitibiott~ 
policy. Thcre is no well-established systeni of l o c ~ l  monitoring of 
resistance in hospitals, so there is a weak influence of these rc\ult\ 011 
updating of antibiotic formularies. Econoinic reasons (the  called 
barter economy) significantly limit the  ability of hospitak to buy 
antibiotics of their choice. Also, the bad niarkcting practices (e.g. u\c 
of data of foreign pharniacoeconomic studies for marketing purpose\, 
advertisements in the niass media, etc.) of some pharmaceuticd 
coinpanies aggravate the above-mentioned probleins. But the niost 
important issue which has not been completely resolved 111 Ilus\ia is 
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the implementation of the ideology of antibiotic policy, stressing the 
unique role of antibiotics. 
Pathogenesis and prevention of polymer- 
associated staphylococcal infections 
Is761 Overview of the clinical presentation and 
problems of polymer-associated staphylococcal 
infections, with special emphasis on 
catheter-related infections 
A. Fleer. University Children's Hospital, Het Wilhelmina 
Kinderziekenhuis, Utrecht, 7'ke Netherlands 
Polymer-associated infections of staphylococci are, in the majority of 
cases, caused by coagulase-negative staphylococcl (CNS) and include 
infections associated with a wide variety of indwelling devices, from 
intravascular catheters to joint and cardiac valve prostheses to cerebro- 
spinal fluid shunts and devices used for peritoneal dialysis. Infection 
is one of the commonest and most serious complications of in- 
dwelling devices. The clinical presentation varies greatly, and 
diagnosis may either be straightforward or extremely difficult. Usually 
there is an indolent clinical picture with low-grade fever and minimal 
local signs of inflammation, e.g. in cases of intravascular catheter- 
related infections or prosthetic joint infections. However, in some 
cases of prosthetic valve endocarditis, there may be a life-threatening 
course characterized by a sudden onset with high fever and chills and 
severe dysfunction of the prosthetic valve. The &ficulties in diagnosis 
of the usual case with an indolent course with minimal clinical signs 
are particularly well illustrated by many cases of intravascular 
catheter-related infection. This had led to numerous attempts to 
provide accurate clinical and microbiological criteria to establish the 
diagnosis of catheter-related infection, with more or less success. 
Some criteria are, for obvious reasons, not easily applicable to certain 
patient categories e.g. multiple blood cultures in premature neonates. 
Others, notably some of the proposed microbiological criteria, 
require methods that are too cumbersome and time-consuming for 
a routine clinical laboratory 
A keen clinical eye remains, more often than not, the most helpful 
instrument for the initial diagnosis; the published clinical criteria may 
aid, together with some of the more advanced microbiological 
methods and scanning techniques, in finally establishing the diagnosis 
of a device-related infection. 
m\ Recent insights into molecular pathogenesis 
M. Herrmann. University of Miinrter, Imt. of Medical Microbiology, 
Minster, Germany 
Staphylococci may colonize foreign material by any of three routes: 
(1) prior to insertion through the surgical wound; (2) after insertion 
through catheter hubs or skin wounds; or (3) hematogeneously, Con- 
sequently, for initial adhesion to the foreign surface, staphylococci 
have to interact either with native or with host factor-adsorbed 
polymer. Both Staphylococcus aureus and coagulase-negative staphylo- 
cocci (CNS) have been shown to avidly interact with proteinaceous 
host factors such as fibronectin and fibrinogen. A number ofbacterial 
adhesins have been implicated in this adhesion process, and the role 
of some of these adhesins has been molecularly characterized. In 
addition to plasma factors, S.  aureus binds to surface-adsorbed blood 
platelets and their membrane-exposed granule contents such as 
thrombospondin or von Willebrand factor (vWF). Molecular analysis 
indicates a role of two fibrinogen-binding adhesins, i.e. Coa/FbpA 
and Efb, in platelet binding, and of protein A in vWF binding. 
Adhesion of CNS to native polymer is mediated by an autolysin, 
AtlE, which influences bacterial surface characteristics and bind$ to 
plasma proteins such as vitronectin. After initial adhesion, staphylo- 
cocci may accumulate on the surface, resulting in biofilm formation. 
Products of the recently identified icaADBC gene cluster in CNS 
confer production of polymerized polysaccharide antigens such as 
PIA and PS/A, are involved in phase variation and are associated with 
clinical disease. Furthermore, biofilm formation requires expression 
of an accumulation-associated protein, AAP. In summary, a number 
of molecularly characterized mechanisms contribute to the ability of 
staphylococci to colonize and infect foreign material. Future research 
activities may be directed towards enhanced understanding of the 
respective role and regulation of these mechanisms under the com- 
plex conditions present in vivo. 
Lessons learned from animal models and from 
use in humans 
D.P. Lew, P. Francois, P. Vaudaux, Hospital Cantonal Universitaire, 
Div. Maladies Infectieuses, Geneva, Switzerland 
Microbial adhesion to foreign material is an initial and fundamental 
mechanism for the development of infection. On their surfaces, 
staphylococci, in particular Staphylococcus aureus, express several 
receptors or adhesins which interact with specific host proteins such 
as fibrinogen, fibronectin, collagen, vitronectin, laminin, thrombo- 
spondin, bone sialoprotein, or elastin. Information on the molecular 
structure of S. aureus genes coding for bacterial adhesins is growing 
rapidly. Cloning, sequencing and site-directed mutagenesis of the 
corresponding genes for major S. aureus adhesins have allowed the 
characterization of the molecular structure and function of one 
fibrinogen-binding protein (=clumping factor), one collagen 
adhesin, and two distinct but related fibronectin-binding proteins. 
Site-specific mutants of each individual adhesin showed specific 
defects in adhesion to their respective host proteins. Furthermore, 
adhesion-defective mutants complemented with functional genes 
(located either on multicopy plasmids or integrated into the bacterial 
chromosome) allowed full restoration of each adhesion phenotype. 
The ligand-binding domains of either fibronectin, fibrinogen or 
collagen adhesins have been identified by binding and inhibition 
studies performed with recombinant truncated protein fragments or 
synthetic peptides. Animal models of endocarditis and bioimplants 
have shown that mutants of S. aureus defective in either a fibronectin 
or a fibrinogen adhesin have less ability to attach and to induce 
experimental infection, Elucidation of molecular mechanisms of 
bacterial attachment to host tissues and biomedical implants as well 
as invasion of non-phagocytic cells may lead to the development of 
better therapeutic approaches for S. aureus infections. 
Clinical impact of new diagnostic methods 
in microbiology 
New automated systems for identification and 
antibiotic resistance detection 
R. Auckenthaler. Laboratoire Central de Bacteriologie, Hopital Cantonal 
Geneva, Switzerland 
Automation of the bacteriology laboratory has not yet become a 
reality. However, new instruments such as the VITEK 2 have recently 
